Compounds > alpha-aminopyridine
Page last updated: 2024-08-21

alpha-aminopyridine and Acquired Autoimmune Hemolytic Anemia

alpha-aminopyridine has been researched along with Acquired Autoimmune Hemolytic Anemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Agajanian, R; Arnold, DM; Boxer, MA; Broome, CM; Choi, M; Field, JJ; Kuter, DJ; Murakhovskaya, I; Numerof, R; Rogers, KA; Tong, S1
Markham, A1

Reviews

1 review(s) available for alpha-aminopyridine and Acquired Autoimmune Hemolytic Anemia

ArticleYear
Fostamatinib: First Global Approval.
    Drugs, 2018, Volume: 78, Issue:9

    Topics: Aminopyridines; Anemia, Hemolytic, Autoimmune; Drug Approval; Glomerulonephritis, IGA; Humans; Morpholines; Oxazines; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Pyrimidines; Syk Kinase; Treatment Outcome

2018

Trials

1 trial(s) available for alpha-aminopyridine and Acquired Autoimmune Hemolytic Anemia

ArticleYear
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
    American journal of hematology, 2022, 06-01, Volume: 97, Issue:6

    Topics: Adult; Aminopyridines; Anemia, Hemolytic, Autoimmune; COVID-19; Humans; Morpholines; Oxazines; Pyridines; Pyrimidines

2022